FEELM Wins Most Promising Innovation Golden Leaf Award

Oct.17.2022
FEELM Wins Most Promising Innovation Golden Leaf Award
FEELM wins Golden Leaf Award for Most Promising Innovation at GTNF, showcasing sustainable commitments and new ceramic coil technology.

FEELM Max has won the Golden Leaf Award for "Most Promising Innovation" (Photo: US Business Information).


The nicotine industry is rapidly innovating, aiming to create a more sustainable world through scientific research and new product development. Dr. Shi, Chief Scientist at SMOLES, participated in a panel discussion on "Products: Innovation for the Future," sharing SMOLES' innovative direction in new electronic cigarette products with hundreds of listeners.


In order to drive continued innovation, Smoore has established 14 basic research institutions around the world, applied for over 4,300 patents, and hired more than 1,200 R&D experts. In terms of safety, Smoore has established a one-stop testing system for EU tobacco product directives and a pre-market tobacco product application (PMTA) testing laboratory for the US. Through these measures, FEELM has not only become a global technology supplier that helps more customer brands pass PMTA, but has also made significant breakthroughs in product safety and nicotine delivery efficiency.


Dr. Shi provided a detailed introduction on these breakthroughs and product development, emphasizing the current trend of harm reduction in tobacco. He stated:


More and more government agencies and non-profit organizations are concerned about the public health risks associated with nicotine addiction, and this is one of the directions for our technological innovation.


We hope to introduce an electronic cigarette with 'low nicotine and high satisfaction' through research.


In addition, discussions at the GTNF primarily focused on environmental issues and promoting the development of a sustainable industry. In May of this year, FEELM announced its net-zero target, aiming to achieve carbon neutrality by 2050. As a supplier of electronic cigarettes, FEELM also released the world's first disposable atomization solution, the FEELM Max, which provides consumers with more flavors, better taste, and greater consistency. Additionally, the product offers multiple puffs for users to enjoy.


Moreover, FEELM's fully automated factory is undergoing upgrades and will be rebuilt as a green factory in the future. This will significantly reduce carbon emissions during the production process and help customers reduce their carbon footprint before introducing products to the market.


At the GTNF, FEELM was awarded the Golden Leaf Award for "Most Promising New Product". Dr. Shi expressed his gratitude to industry partners at the awards ceremony, thanking them for their support and trust in FEELM since its initial launch, as well as their ongoing support over the years. Looking ahead, he promised to work alongside partners to bring better technology and products to consumers in need.


Regarding the Global Tobacco and Nicotine Forum (GTNF):


The Global Tobacco and Nicotine Forum (GTNF) is an annual forum that leads discussions on the future of the tobacco and nicotine industry. Founded on the principle of promoting positive dialogue and expanding perspectives, GTNF aims to empower attendees to shape the future together. Since its establishment in Rio de Janeiro in 2008, GTNF has become an international platform for public health experts, government representatives, industry leaders, and investors to exchange views and ideas. Global tobacco giants such as British American Tobacco (BAT), Philip Morris International (PMI), and Altria also participated in the event over the past three days and shared their viewpoints.


About FEELM:


FEELM, owned by SMOK, is a leading provider of closed electronic cigarette systems worldwide. Their flagship technology is based on advanced ceramic heating technology and incorporates cutting-edge electronic technology and design to achieve maximum flavor and a superior vaping experience for their users.


Regarding Simalu:


Smok is a leading global provider of electronic cigarette technology solutions, which includes the production of electronic cigarette devices, as well as providing electronic cigarette components for the production of heat-not-burn tobacco products (HNB) via an original design manufacturing (ODM) approach. The company boasts advanced R&D technology, strong manufacturing capabilities, a wide product portfolio, and a diverse customer base.


According to data from Frost & Sullivan, Smoore is the leading manufacturer of electronic cigarette devices worldwide, accounting for 22.8% of the total global market share in terms of revenue in 2021. Its global market share exceeds the combined total of companies ranked second through fifth.


Statement:


This article is compiled from third-party information and is intended solely for industry discussion and learning purposes.


This article does not reflect the viewpoints of 2FIRSTS. Additionally, 2FIRSTS cannot verify the truthfulness or accuracy of the article's content. The translation of this article is solely intended for industry-related communication and research.


Due to limitations in our translation abilities, the compiled article may not fully express the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02